Jiangsu Hansoh Pharmaceutical Group Co Ltd

Overview

Jiangsu Hansoh Pharmaceutical Group Co Ltd (Hansoh Pharma), a subsidiary of Hansoh Pharmaceutical Group Co Ltd, carries out the research, development, manufacturing and distribution of pharmaceutical drug products. The company offers tablets, capsules, injections and anti-infective drugs for the therapeutic areas including diabetes, infectious diseases, central nervous system, oncology, gastrointestinal and cardiovascular indications. Its products include Donepezil Hydrochloride Tablets, Olanzapine Tablets, ambrisentan tablets, gemcitabine hydrochloride for injection, imatinib mesylate tablets, vinorelbine tartrate injection and repaglinide tablets, among others. Hansoh Pharma markets its products under Fulaidi, Fulairui, Fulaixin, Xintai, Zefei, Xinwei, Gainuo, Nuoxin, Zetan, Meifeng, Hengte and other brands. The company also operates research and development center in Shanghai, China. Hansoh Pharma is headquartered in Lianyungang City, Jiangsu, China.
Key Stats
Address
No. 9 Dongjin Road, Economic & Technical Development Zone, Lianyungang, Jiangsu
Headquarters

China

Website
www.hspharm.com
No of Employees

12,030

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

3692 [HKG]

Revenue (2020)

$1,259 m

0.2% (2020 vs 2019)
Net Income (2020)

$372 m

0.5% (2020 vs 2019)
Net Profit Margin

30 %

0.4% (2020 vs 2019)
Market Cap *

$14,012 m

EPS *

$0.4

  *Note: Ratios based on the share price as of 6-October-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Jiangsu Hansoh Pharmaceutical Group Co Ltd
Key Information
Headquarters China
Headquarter City Lianyungang
Headquarter State/Province Jiangsu
No. of Employees 12,030
Entity Type Public

Products & Services

Hansoh Pharma develops, manufactures and supplies pharmaceutical products. Key products and brands offered by the company include the following:

Products
  • Product Forms:
  • Tablets
  • Capsules
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • API Chemical
Brands
  • Fulaidi
  • Fulairui
  • Fulaixin
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2020 Contracts/Agreements In April, the company and NiKang Therapeutics entered into a collaboration to focus on development…
2020 Contracts/Agreements In July, the company and EQRxa entered into a strategic collaboration and licensing agreement to…
2020 Contracts/Agreements In July, Hansoh Pharma and Terns Pharmaceuticals signed a collaboration and license agreement to develop…
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2015 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target